| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
| | | Operating Expenses | | Research Development | 3,929 | 4,220 | 3,581 | | Selling General and Administrative | 2,973 | 3,085 | 3,904 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (6,902) | (7,305) | (7,485) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 582 | 488 | 441 | | Earnings Before Interest And Taxes | (6,320) | (6,817) | (7,044) | | Interest Expense |
-
|
-
| 2 | | Income Before Tax | (6,320) | (6,817) | (7,046) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,320) | (6,817) | (7,046) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (6,320) | (6,817) | (7,046) | | Preferred Stock And Other Adjustments | (3,426) | (6,948) | (3,329) | | | Net Income Applicable To Common Shares | ($9,746) | ($13,765) | ($10,375) |
|
0.20% Nasdaq 
Income Statement
